225 related articles for article (PubMed ID: 22074281)
1. Anticoagulant counter ion impact on bioanalytical LC-MS/MS assays: results from discussions and experiments within the European Bioanalysis Forum.
Sennbro CJ; Knutsson M; van Amsterdam P; Timmerman P
Bioanalysis; 2011 Nov; 3(21):2393-9. PubMed ID: 22074281
[TBL] [Abstract][Full Text] [Related]
2. Confirmation of no impact from different anticoagulant counter ions on bioanalytical method.
Bergeron A; Bergeron M; Garofolo F
Bioanalysis; 2012 May; 4(8):897-908. PubMed ID: 22533564
[TBL] [Abstract][Full Text] [Related]
3. EBF: reflection on bioanalytical assay requirements used to support liquid microsampling.
White S; Hawthorne G; Dillen L; Spooner N; Woods K; Sangster T; Cobb Z; Timmerman P
Bioanalysis; 2014; 6(19):2581-6. PubMed ID: 25411700
[No Abstract] [Full Text] [Related]
4. European Bioanalysis Forum continued plans to support liquid microsampling.
Timmerman P; White S; Cobb Z; Woods K; de Vries R; Spooner N; Sangster T; Dillen L; Hawthorne G
Bioanalysis; 2014; 6(14):1897-900. PubMed ID: 25158961
[No Abstract] [Full Text] [Related]
5. Validating regulatory-compliant wide dynamic range bioanalytical assays using chip-based nanoelectrospray tandem mass spectrometry.
Wickremsinhe ER; Ackermann BL; Chaudhary AK
Rapid Commun Mass Spectrom; 2005; 19(1):47-56. PubMed ID: 15570573
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant counter ion impact on bioanalytical LC-MS/MS assay performance: additional validation required?
Sennbro CJ; Knutsson M; Timmerman P; van Amsterdam P
Bioanalysis; 2011 Nov; 3(21):2389-91. PubMed ID: 22074280
[No Abstract] [Full Text] [Related]
7. Feedback from the European Bioanalysis Forum liquid microsampling consortium: capillary liquid microsampling and assessment of homogeneity of the resultant samples.
Cobb Z; Rohde M; Love I; Boutet V; Schroeter K; Hawthorne G; Dillen L; Barfield M; Kandira A; Kranenborgh M; White S; Timmerman P
Bioanalysis; 2019 Mar; 11(6):525-532. PubMed ID: 30973017
[TBL] [Abstract][Full Text] [Related]
8. Impact of plasma and whole-blood anticoagulant counter ion choice on drug stability and matrix effects during bioanalysis.
Bergeron M; Bergeron A; Furtado M; Garofolo F
Bioanalysis; 2009 Jun; 1(3):537-48. PubMed ID: 21083151
[TBL] [Abstract][Full Text] [Related]
9. Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery.
Mei H; Hsieh Y; Nardo C; Xu X; Wang S; Ng K; Korfmacher WA
Rapid Commun Mass Spectrom; 2003; 17(1):97-103. PubMed ID: 12478560
[TBL] [Abstract][Full Text] [Related]
10. European Bioanalysis Forum recommendation: scientific validation of quantification by accelerator mass spectrometry.
Higton D; Young G; Timmerman P; Abbott R; Knutsson M; Svensson LD
Bioanalysis; 2012 Nov; 4(22):2669-79. PubMed ID: 23210650
[TBL] [Abstract][Full Text] [Related]
11. Direct analysis in real time coupled with dried spot sampling for bioanalysis in a drug-discovery setting.
Crawford E; Gordon J; Wu JT; Musselman B; Liu R; Yu S
Bioanalysis; 2011 Jun; 3(11):1217-26. PubMed ID: 21649498
[TBL] [Abstract][Full Text] [Related]
12. Rapid analysis of dried blood spot samples with sub-2-µm LC-MS/MS.
Mather J; Rainville PD; Spooner N; Evans CA; Smith NW; Plumb RS
Bioanalysis; 2011 Feb; 3(4):411-20. PubMed ID: 21338261
[TBL] [Abstract][Full Text] [Related]
13. Feedback from the European Bioanalysis Forum liquid microsampling consortium: microsampling: assessing accuracy and precision of handheld pipettes and capillaries.
Hawthorne G; Dillen L; Barfield M; Cobb Z; Kandira A; Schroeter K; White S; Karp NA; Love I; Boutet V; Rohde M; Kranenborgh M; Timmerman P
Bioanalysis; 2019 Mar; 11(6):533-542. PubMed ID: 30973018
[No Abstract] [Full Text] [Related]
14. Liquid chromatography/tandem mass spectrometry sensitivity enhancement via online sample dilution and trapping: applications in microdosing and dried blood spot (DBS) bioanalysis.
Li F; Zulkoski JP; Ding J; Brown W; Addison T
Rapid Commun Mass Spectrom; 2010 Sep; 24(17):2575-83. PubMed ID: 20740533
[TBL] [Abstract][Full Text] [Related]
15. Evaluating and defining sample preparation procedures for DBS LC-MS/MS assays.
Liu G; Patrone L; Snapp HM; Batog A; Valentine J; Cosma G; Tymiak A; Ji QC; Arnold ME
Bioanalysis; 2010 Aug; 2(8):1405-14. PubMed ID: 21083341
[TBL] [Abstract][Full Text] [Related]
16. EBF recommendation on the validation of bioanalytical methods for dried blood spots.
Timmerman P; White S; Globig S; Lüdtke S; Brunet L; Smeraglia J
Bioanalysis; 2011 Jul; 3(14):1567-75. PubMed ID: 21749218
[TBL] [Abstract][Full Text] [Related]
17. Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum.
Timmerman P; Luedtke S; van Amsterdam P; Brudny-Kloeppel M; Lausecker B; Fischmann S; Globig S; Sennbro CJ; Jansat JM; Mulder H; Thomas E; Knutsson M; Kasel D; White SA; Kall MA; Mokrzycki-Issartel N; Freisleben A; Romero F; Andersen MP; Knebel N; de Zwart M; Laakso S; Hucker RS; Schmidt D; Gordon B; Abbott R; Boulanger P
Bioanalysis; 2009 Sep; 1(6):1049-56. PubMed ID: 21083073
[TBL] [Abstract][Full Text] [Related]
18. A strategy for high-throughput analysis of levosimendan and its metabolites in human plasma samples using sequential negative and positive ionization liquid chromatography/tandem mass spectrometric detection.
Zhang J; Gage EM; Ji QC; El-Shourbagy TA
Rapid Commun Mass Spectrom; 2007; 21(14):2169-76. PubMed ID: 17631672
[TBL] [Abstract][Full Text] [Related]
19. Human DBS sampling with LC-MS/MS for enantioselective determination of metoprolol and its metabolite O-desmethyl metoprolol.
Liang X; Jiang H; Chen X
Bioanalysis; 2010 Aug; 2(8):1437-48. PubMed ID: 21083344
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a high-throughput online solid phase extraction-tandem mass spectrometry system for in vivo bioanalytical studies.
Jian W; Romm MV; Edom RW; Miller VP; LaMarr WA; Weng N
Anal Chem; 2011 Nov; 83(21):8259-66. PubMed ID: 21936562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
